|
|
Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases
|
He Feng, Quan Yibo, Lei Ming, Liu Riguang, Qin Shuguang, Zeng Jun, Zhao Ziwen, Yu Na, Yang Liuping, Cao Jie
|
|
|
Table 2 Risk factors of ICU admission for COVID-19 patients with CVD. |
|
| | Univariable OR (95% CI) | p value | Multivariable OR (95% CI) | p value |
---|
Age, years | 1.09 (1.02-1.15) | 0.010 | 1.08 (1.02-1.17) | 0.018 | Female sex (vs. male) | 0.24 (0.06-0.91) | 0.036 | 0.18 (0.29-1.06) | 0.058 | Diabetes | 1.76 (0.48-6.46) | 0.396 | .. | .. | Chronic kidney disease | 3.44 (0.52-22.64) | 0.199 | .. | .. | COPD | 1.72 (0.17-17.83) | 0.650 | .. | .. | Cerebrovascular disease | 1.64 (0.30-9.05) | 0.57 | .. | .. | Fever | 1.63 (0.47-5.63) | 0.444 | .. | .. | Cough | 2.83 (0.73-10.93) | 0.132 | .. | .. | Respiratory rate ≥24 breaths per min | 37.77 (5.52-258.28) | <0.0001 | 25.52 (5.48-118.87) | <0.0001 | White blood cell count, ×109/L | | ≤4 | 0 | 0.999 | .. | .. | | 4-10 | 1(ref) | .. | .. | .. | | >10 | 2.77 (0.42-18.31) | 0.291 | .. | .. | Lymphocyte count, ×109/L | | <1.1 | 5.78 (1.74-19.18) | 0.004 | 0.47 (0.15-1.52) | 0.210 | | ≥1.1 | 1(ref) | .. | 1(ref) | .. | Procalcitonin, ng/mL | | <0.05 | 1(ref) | .. | 1(ref) | .. | | 0.05-10 | 4.07 (0.78-21.27) | 0.096 | 4.13 (0.42-40.77) | 0.225 | | >10 | 1.31 (0.22-7.87) | 0.768 | 0.48 (0.03-7.44) | 0.602 | C-reactive protein, mg/L | | <10 | 1(ref) | .. | 1(ref) | .. | | ≥10 | 24.57 (5.69-106.13) | <0.0001 | 8.12 (1.63-40.49) | 0.011 | Troponin I, ug/L | | ≤0.03 | 1(ref) | .. | 1(ref) | .. | | >0.03 | 14.72 (5.03-43.13) | <0.0001 | 9.14 (2.66-31.43) | <0.0001 | BNP, 100 μg/L | | ≤100 | 1(ref) | .. | .. | .. | | >100 | 60 (5.47-658.76) | 0.001 | .. | .. | Creatinine, μmol/L | | ≤106 | 1(ref) | .. | 1(ref) | .. | | >106 | 5.31 (1.25-22.60) | 0.024 | 2.00 (0.18-22.08) | 0.572 |
|
|
|